These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 4387977)

  • 21. Fate of norepinephrine in sympathetic nerons and by cardiovascular drugs.
    Axelrod J; Wurtman RJ
    N Y State J Med; 1968 Jan; 68(2):252-6. PubMed ID: 4383958
    [No Abstract]   [Full Text] [Related]  

  • 22. [A controlled blind study of 4 antihypertensive agents (methyldopa and 3 sympatholytic agents)].
    Vejlsgaard V; Christensen M; Clausen E
    Ugeskr Laeger; 1967 May; 129(19):635-8. PubMed ID: 4877293
    [No Abstract]   [Full Text] [Related]  

  • 23. Adynamic ileus, its pathogenesis and treatment.
    Furness JB; Costa M
    Med Biol; 1974 Apr; 52(2):82-9. PubMed ID: 4365867
    [No Abstract]   [Full Text] [Related]  

  • 24. Patterns of blood-pressure during chronic administration of postganglionic sympathetic blocking drugs for hypertension.
    Goldberg AD; Raftery EB
    Lancet; 1976 Nov; 2(7994):1052-4. PubMed ID: 62901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. THE USE OF BETHANIDINE IN THE TREATMENT OF HYPERTENSION.
    JOHNSTON AW; PRICHARD BN; ROSENTHEIM ML
    Lancet; 1964 Sep; 2(7361):659-61. PubMed ID: 14188906
    [No Abstract]   [Full Text] [Related]  

  • 26. Distribution of guanidinium antihypertensives--mechanism of their selective action.
    Oates JA; Mitchell JR; Feagin OT; Kaufmann JS; Shand DG
    Ann N Y Acad Sci; 1971 Jul; 179():302-9. PubMed ID: 5285379
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pharmacological effects of [(octahydro-2-azocinyl)methyl] guanidine(guanazodine): its action mechanism and hypotensive effect].
    Shimizu T; Hamakawa H; Tozuka T; Ono H
    Nihon Yakurigaku Zasshi; 1976 Oct; 72(7):837-50. PubMed ID: 1035187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sympathetic activity in essential hypertension.
    Koch-Weser J
    N Engl J Med; 1973 Mar; 288(12):627-9. PubMed ID: 4405674
    [No Abstract]   [Full Text] [Related]  

  • 29. [Drugs in the management of arterial hypertension].
    Rev Clin Esp; 1969 Jan; 112(2):207. PubMed ID: 5769042
    [No Abstract]   [Full Text] [Related]  

  • 30. Factors predisposing to postural hypotensive symptoms in the treatment of high blood pressure.
    Talbot S; Smith AJ
    Br Heart J; 1975 Oct; 37(10):1059-63. PubMed ID: 127594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative clinical trial of guanoxan and guanethidine in essential hypertension.
    Ruedy J; Davies RO
    Clin Pharmacol Ther; 1967; 8(1):38-47. PubMed ID: 5334083
    [No Abstract]   [Full Text] [Related]  

  • 32. Adverse reactions and interactions limiting the use of antihypertensive drugs.
    Nies AS
    Am J Med; 1975 Apr; 58(4):495-503. PubMed ID: 235842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Should antihypertensive drugs be discontinued before surgery?].
    Stenbaek O
    Tidsskr Nor Laegeforen; 1971 Apr; 91(10):735-7. PubMed ID: 4397026
    [No Abstract]   [Full Text] [Related]  

  • 34. Antihypertensive pharmacotherapy.
    Hayes AH; Schneck DW
    Postgrad Med; 1976 May; 59(5):155-62. PubMed ID: 57611
    [No Abstract]   [Full Text] [Related]  

  • 35. 2,6-Dichlorobenzylidene amino guanidine acetate (Wy-8678). A new hypotensive agent.
    Baum T; Eckfeld DK; Metz N; Dinish JL; Rowles G; Van Pelt R; Shropshire AT; Fernandez SP; Gluckman MI; Bruce WF
    Experientia; 1969 Oct; 25(10):1066-7. PubMed ID: 5357105
    [No Abstract]   [Full Text] [Related]  

  • 36. THE EFFECTS OF BETHANIDINE ON THE PERIPHERAL CIRCULATION IN MAN.
    FEWINGS JD; HODGE RL; SCROOP GC; WHELAN RF
    Br J Pharmacol Chemother; 1964 Aug; 23(1):115-22. PubMed ID: 14208188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal of guanethidine blockade of sympathetic nerve terminals by tetraethylammonium and 4-aminopyridine.
    Kirpekar M; Kirpekar SM; Prat JC
    Br J Pharmacol; 1978 Jan; 62(1):75-8. PubMed ID: 620099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The adrenergic neurone blocking action of [2-(methylphenylamino)-ethyl]guanidine sulfate. II.
    Ozawa H; Sato S
    Chem Pharm Bull (Tokyo); 1967 Jun; 15(6):840-4. PubMed ID: 4383841
    [No Abstract]   [Full Text] [Related]  

  • 39. [Ambulant long-term treatment of arterial hypertension].
    Mühlberg H; Mühlberg G
    Z Gesamte Inn Med; 1965 Aug; 20(15):Suppl:90-3. PubMed ID: 4379548
    [No Abstract]   [Full Text] [Related]  

  • 40. [Principles and management of antihypertensive treatments].
    Cardiol Prat; 1973; 24(3):335-8. PubMed ID: 4149895
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.